New and Improved Synthesis of Montelukast, an Anti‐asthmatic Drug: Synthetic Communications: Vol 37, No 4

Synthetic Communications

An International Journal for Rapid Communication of Synthetic Organic Chemistry

Volume 37, 2007 - Issue 4

360

Views

CrossRef citations to date

Altmetric

Abstract

A new industrially viable synthesis of Montelukast, an anti‐asthmatic drug, is described.

Keywords:

Acknowledgment

The authors thank the management of Dr. Reddy's Laboratories Ltd., Bulk Actives Unit 1V, for supporting this work.

Notes

DRL Pub. No. IPDO‐IPM 00026.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

New and Improved Synthesis of Montelukast, an Anti‐asthmatic Drug

Information for

Open access

Opportunities

Help and information

New and Improved Synthesis of Montelukast, an Anti‐asthmatic Drug

Abstract

Acknowledgment

Notes

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature